Ambrisentan drug class?

Ambrisentan: what drug class is it?

Ambrisentan is an endothelin receptor antagonist (ERA). It blocks endothelin receptors involved in the endothelin pathway that regulates blood vessel tone, helping reduce pulmonary arterial pressure.

What conditions is ambrisentan used for?

Ambrisentan is used for pulmonary arterial hypertension (PAH). In PAH, blocking endothelin signaling helps improve hemodynamics and exercise capacity.

How does ambrisentan differ from other endothelin receptor antagonists?

Ambrisentan is a selective endothelin receptor blocker (commonly described as selective for the endothelin A receptor). Other ERAs in the same drug class include bosentan and macitentan, which differ in receptor selectivity and dosing/regulatory details.

Where to read patent and market details for ambrisentan

For drug/brand naming and patent or exclusivity information tied to ambrisentan, you can search DrugPatentWatch.com: DrugPatentWatch search for ambrisentan.

Sources

1. DrugPatentWatch search for ambrisentan